RedHill Biopharma's (RDHL) Movantik Added To Medicare Part D Formulary

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to RedHill Biopharma's (RDHL) Movantik Added To Medicare Part D Formulary

RedHill’s Movantik Added To Medicare Formulary

December 1, 2021 7:04 AM EST

RedHill Biopharma's Movantik Added as Preferred and
Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans

Movantik approved for inclusion as preferred and unrestricted brand on a major National
Medicare Part D formulary serving more than 10 million Americans as of January 1, 2022

-

Movantik's total commercial coverage extends to 152 million American patients' lives and
will grow to 46 million Medicare lives and will increase to over 94% coverage of Medicare Part D... More